Mesentech
Mesentech is a clinical stage biotechnology company developing novel medicines that selectively distribute to the intended site of action. MES1022 is a clinical stage program for bone-repair being developed for 3 indications. Our preclinical pipeline includes novel compounds targeting bone-cancers.
7-day free trial · no credit card
Verified contacts
7
available on Kipplo
LinkedIn employees
11
11 to 50 range
Open roles
—
no listings
Distinct roles
6
indexed titles
Tech stack
1
tools in use
Monthly traffic
35
organic / mo
Sign up free to see all 7 verified contacts at Mesentech
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
7 contacts with verified email or phone · masked until revealed.
- AS
Alicia Schiavi
Director Clinical Operations · Operations
EmailPhone - SK
Srinivas Kantham
Senior Scientist · Science
EmailPhone - GC
Gang Chen
Director of Medicinal Chemistry · Other
EmailPhone - JP
Jonathan Polak
Chief Executive Officer · Other
EmailPhone - KL
Karen Long
Sr Director Development · Other
EmailPhone
Showing 5 of 7 verified contacts
Top roles at Mesentech
6 distinct titles indexed · top 6 shown.
- 2director of medicinal chemistry
- 1chief executive officer
- 1director clinical operations
- 1senior scientist
- 1sr director development
- 1surgical and biomaterials consultant
Sign up to unlock all 7 contacts at Mesentech
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 7 verified contacts at Mesentech
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.